Nueclear Web Banner
Users Online: 482
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Management of relapsed-refractory diffuse large B cell lymphoma

Raut Lalit S, Chakrabarti Prantar P

Year : 2014| Volume: 3| Issue : 1 | Page no: 66-70

   This article has been cited by
 
1 Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma
Lucia Baratto,Guido A. Davidzon,Mateen Moghbel,Negin Hatami,Andrei Iagaru,Erik S. Mittra
Clinical Nuclear Medicine. 2018; 43(1): 1
[Pubmed]  [Google Scholar] [DOI]
2 The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)
Peter D. Whooley,Russell K. Dorer,David M. Aboulafia
Leukemia Research Reports. 2018; 9: 48
[Pubmed]  [Google Scholar] [DOI]
3 A novel anti-CD22 scFv–apoptin fusion protein induces apoptosis in malignant B-cells
Solmaz Agha Amiri,Soraya Shahhosseini,Najmeh Zarei,Dorsa Khorasanizadeh,Elahe Aminollahi,Faegheh Rezaie,Mehryar Zargari,Mohammad Azizi,Vahid Khalaj
AMB Express. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
4 Chimeric Antigen Receptor T-Cell Therapy for Lymphomas
Benjamin Jolley,Scot Walker
Hospital Pharmacy. 2017; 52(7): 469
[Pubmed]  [Google Scholar] [DOI]
5 Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?
Amit Dipak Amin,Tara L. Peters,Lingxiao Li,Soumya Sundara Rajan,Ramesh Choudhari,Soham D. Puvvada,Jonathan H. Schatz
Molecular Case Studies. 2017; 3(3): a001719
[Pubmed]  [Google Scholar] [DOI]
6 Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
Hina J. Shah,Abhishek R. Keraliya,Jyothi P. Jagannathan,Sree Harsha Tirumani,Vikram R. Lele,Pamela J. DiPiro
Korean Journal of Radiology. 2017; 18(1): 54
[Pubmed]  [Google Scholar] [DOI]
7 Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway
Zhanshan Cha,Guangfang Qian,Yan Zang,Haihui Gu,Yanyan Huang,Lishuang Zhu,Jinqi Li,Yang Liu,Xiaohua Tu,Haihan Song,Baohua Qian
Experimental Cell Research. 2017; 350(1): 154
[Pubmed]  [Google Scholar] [DOI]
8 PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma
Wei Zhang,Jie-Fei Bai,Meng-Xuan Zuo,Xin-Xin Cao,Miao Chen,Yan Zhang,Xiao Han,Ding-Rong Zhong,Dao-Bin Zhou
Cancer Medicine. 2016; 5(11): 3077
[Pubmed]  [Google Scholar] [DOI]
9 Antitumor activity of fucoidan against diffuse large B cell lymphomain vitroandin vivo
Guang Yang,Qianqiao Zhang,Yuanyuan Kong,Bingqian Xie,Minjie Gao,Yi Tao,Hongwei Xu,Fenghuang Zhan,Bojie Dai,Jumei Shi,Xiaosong Wu
Acta Biochimica et Biophysica Sinica. 2015; 47(11): 925
[Pubmed]  [Google Scholar] [DOI]
10 A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma
Hongli Zhao,Guoxun Sun,Desheng Kong,Yujing Zhang,Wudan Shi,Mingming Zhao,Luojia Hong,Zhenkui Qiao
Medical Oncology. 2015; 32(3)
[Pubmed]  [Google Scholar] [DOI]
11 Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin’s lymphoma patients with a poor performance status or comorbidity
XUEDE LIN,XI SHI,WUCHA ZENG,MIN ZHENG,LIMING HUANG
Oncology Letters. 2014; 8(5): 2012
[Pubmed]  [Google Scholar] [DOI]

 

Read this article